Post Profile






Related Posts


AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): A Big Pharma Company With a Juicy Dividend Yield and Low Valuation

Business & Finance / Investing : Insider Monkey

Recently, AstraZeneca plc (ADR) (NYSE:AZN) announced that it has agreed to acquire Pearl Therapeutics, the respiratory drug manufacturer, in a transaction worth around $1.15 billion. Since the beginning of the year, AstraZeneca plc ...

AstraZeneca plans new pivotal lung cancer trial with Incyte

Health : Reuters: Health

LONDON (Reuters) - AstraZeneca is stepping up its bet on immunotherapy combination treatments to fight lung cancer by signing a deal with Incyte under which the two companies will start a final-stage Phase III clinical trial next ye...

Array Biopharma Inc (ARRY), AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): This Cancer Biotech Is Looking for Other Green Pastures

Business & Finance / Investing : Insider Monkey

Array Biopharma Inc (NASDAQ:ARRY), a biotech company primarily focused on discovery of drugs for cancer treatment, is making forays into the asthma market. The company recently announced encouraging results – 6.8% improvement in FEV...

FDA approves AstraZeneca's Calquence for rare blood cancer

Health : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Tuesday it approved AstraZeneca Plc's Calquence as a treatment for a rare type of blood cancer.

AstraZeneca gets breakthrough status for blood cancer drug

Health : Reuters: Health

LONDON (Reuters) - AstraZeneca said on Tuesday that U.S. regulators had awarded its blood cancer drug acalabrutinib "breakthrough" status for the treatment of patients with mantle cell lymphoma, a rare type of blood cancer.

Comments


Copyright © 2016 Regator, LLC